UBS Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-29,006
| Closed | -$784K | – | 9021 |
|
2024
Q2 | $784K | Sell |
29,006
-27,175
| -48% | -$735K | ﹤0.01% | 3601 |
|
2024
Q1 | $1.03M | Buy |
56,181
+35,275
| +169% | +$646K | ﹤0.01% | 3531 |
|
2023
Q4 | $257K | Buy |
20,906
+14,648
| +234% | +$180K | ﹤0.01% | 4443 |
|
2023
Q3 | $93.8K | Sell |
6,258
-5,292
| -46% | -$79.3K | ﹤0.01% | 4757 |
|
2023
Q2 | $375K | Buy |
11,550
+424
| +4% | +$13.8K | ﹤0.01% | 4046 |
|
2023
Q1 | $435K | Buy |
11,126
+7,352
| +195% | +$288K | ﹤0.01% | 3802 |
|
2022
Q4 | $199K | Buy |
3,774
+3,083
| +446% | +$163K | ﹤0.01% | 4367 |
|
2022
Q3 | $31K | Sell |
691
-104
| -13% | -$4.67K | ﹤0.01% | 5764 |
|
2022
Q2 | $29K | Sell |
795
-168
| -17% | -$6.13K | ﹤0.01% | 5419 |
|
2022
Q1 | $40K | Sell |
963
-991
| -51% | -$41.2K | ﹤0.01% | 5685 |
|
2021
Q4 | $83K | Buy |
1,954
+1,032
| +112% | +$43.8K | ﹤0.01% | 5397 |
|
2021
Q3 | $51K | Sell |
922
-121
| -12% | -$6.69K | ﹤0.01% | 5217 |
|
2021
Q2 | $50K | Sell |
1,043
-809
| -44% | -$38.8K | ﹤0.01% | 5372 |
|
2021
Q1 | $94K | Sell |
1,852
-452
| -20% | -$22.9K | ﹤0.01% | 5030 |
|
2020
Q4 | $145K | Sell |
2,304
-4,461
| -66% | -$281K | ﹤0.01% | 4479 |
|
2020
Q3 | $455K | Buy |
6,765
+208
| +3% | +$14K | ﹤0.01% | 3499 |
|
2020
Q2 | $275K | Buy |
6,557
+57
| +0.9% | +$2.39K | ﹤0.01% | 3794 |
|
2020
Q1 | $205K | Sell |
6,500
-2,887
| -31% | -$91.1K | ﹤0.01% | 3879 |
|
2019
Q4 | $380K | Buy |
9,387
+9,032
| +2,544% | +$366K | ﹤0.01% | 4117 |
|
2019
Q3 | $292K | Sell |
355
-1,117
| -76% | -$919K | ﹤0.01% | 4097 |
|
2019
Q2 | $72K | Buy |
+1,472
| New | +$72K | ﹤0.01% | 4778 |
|